According to BTIG Research, value stocks are closing at a 40-year low relative to growth. The primary reason is that ...

Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Inari Medical (NasdaqGS:NARI) from Buy to Neutral.

BTIG Research has recently reduced Fiverr International Ltd (FVRR) stock to Neutral rating, as announced on November 4, 2024, according to Finviz. Earlier, on July 2, 2024, UBS had reduced the stock ...

BTIG raised the firm’s price target on MoonLake Immunotherapeutics (MLTX) to $81 from $71 and keeps a Buy rating on the shares. The firm ...

In a report released today, Ryan Zimmerman from BTIG reiterated a Buy rating on Globus Medical (GMED – Research Report), with a price target of ...

First Hawaiian Bank grew its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 4.6% in the ...

BTIG Research has recently reduced Beyond Air Inc (XAIR) stock to Neutral rating, as announced on June 25, 2024, according to Finviz. Earlier, on July 28, 2023, Piper Sandler had initiated the stock ...

Carisma Therapeutics, Inc. (NASDAQ:CARM – Get Free Report) has earned an average recommendation of “Hold” from the seven ...

BTIG raised the firm’s price target on Glaukos (GKOS) to $157 from $149 and keeps a Buy rating on the shares as part of a broader research note updating the firm’s models on Medical Technology names ...

SunCar Technology Group (NASDAQ:SDA) is on watch after BTIG Research initiated coverage on the cloud-based provider of digitalized automotive services and auto e-insurance solutions with a Buy rating.

BTIG analyst Marie Thibault raised the firm’s price target on Boston Scientific (BSX) to $101 from $97 and keeps a Buy rating ...

and at the low end from Microsoft (MSFT), the analyst tells investors in a research note. BTIG contends however that trends are “moving in the right direction” as net new annual recurring ...